Molzym Operational Status - Statement to COVID-19

23 March 2020

Covid 19 141427609 340x255 blauAs COVID-19 continues to impact the globe we want to address how Molzym is dealing with the current situation.

Operational Status
We are fully operational and have not experienced any impact on resources and logistics yet and process orders as usual. For the safety of our customers and employees, Molzym is taking any precautions to prevent the spread of COVID-19. Therefore, we have implemented strict travel restrictions and whenever possible our staff is working from home office.

Manufacturing & Shipping
We have implemented a shift-based system for production, assembly, processing and shipment of orders. Two teams plus backup staff are working without having direct contact to each other to ensure the supply of your products as you are used to. We are permanently monitoring our supply chain and are in close contact to our suppliers and freight forwarders to understand and identify any risks in supplies and shipments as early as possible. If there are any delays in production or delivery we will notify you immediately.

Customer Service & Technical Support
Our Customer service and technical support is available during regular business hours to help you with your needs and to answer your questions on the phone or via e-mail.

We will continue to monitor the COVID-19 situation and will update our operational status if needed. 

Please follow the link for the pdf version of this statement.


Molzym is Now Part of Gradian Diagnostics!

16 December 2019


We are very pleased to inform you that Molzym GmbH & Co. KG has joined Gradian Diagnostics. Being part of Gradian Diagnostics allows us to accelerate growth and develop new innovative solutions that help hospitals and labs with the challenges and opportunities they face today and in the future in routine microbial pathogen diagnostics and molecular microbiology research.

Our highly experienced team of researchers, technicians and diagnostic specialists in addition to our businesses and services will remain unchanged. Our customers, distributors and partners can continue to rely on our high quality solutions and our excellent support. The offices and production site will remain in Bremen, Germany.

Gradian Diagnostics is a holding company based in Miami, USA, working on expanding diagnostic solutions by acquiring assets and companies with validated products around the world. Please follow the link for the official press release.


Molzym - Sample to Microbe


Stadtmusikanten webMolzym was founded as a privately owned enterprise in Bremen, North-West Germany, in 2003. Ever since, Molzym has been committed to the development of innovative solutions to serve biological research and diagnosis of infectious diseases. Our developmental efforts are particularly focused on new processes enabling and facilitating the molecular diagnosis of infectious diseases caused by bacteria and fungi. Meanwhile, more than 50 high quality products are available for molecular microbial analysis by PCR-, hybridization- and NGS-based methods in 30 countries worldwide.


Molzym manufactures ultra-clean and highly active amplification reagents and kits for microbial nucleic acid extraction from a variety of specimens. In particular, reagents and consumables are supplied free of contaminating microbial DNA – guaranteed lot by lot. Our customers appreciate the ability of increasing the number of amplification cycles and thus lowering the limit of detection dramatically without false positive results arising from contaminating microbial DNA. Another core expertise is Molzym’s unique technology of the depletion of human DNA, a well-known factor negatively influencing sensitive PCR and microbiome analysis at low microbial loads.


MolYsis™ is Molzym’s proprietary technology of human DNA depletion allowing targeted isolation of microbial DNA from a variety of clinical samples, including whole blood, CSF, BAL, joint aspirates, tissue biopsies, abscesses and other material. Ultra-pure, DNA-free PCR reagents and master mixes allow for the precise detection and monitoring of aetiologies of infectious diseases in humans and animal models. Complete assays for the broad-range amplification of selected regions of the 16S and 18S rRNA genes of bacteria and fungi are available for PCR analysis at 40 cycles. Basic and dye master mixes can be used with custom primers for PCR and Real-Time PCR analysis.


The latest development is a walk-away robotic system, SelectNA™plus, for the fully automated human DNA depletion and extraction of microbial DNA from clinical and other material. SelectNA™plus conveys utmost technical advances to the demands for contamination-free and low-hands-on processing of samples for highest detection sensitivity of pathogens.


Molzym offers a service for the decontamination of customized master mixes from microbial DNA for improved assay performance at increased amplification cycles. Molzym offers opportunities for collaborations that are directed to the development and manufacturing of individualized, pre-analytic and analytic adaptations, including automated DNA isolation. Molzym has developed a broad portfolio of patented technologies and reagents for pathogen-DNA enrichment, isolation and detection, including PCR and NGS applications.

The Molzym team appreciates your interest and is at your disposal for further information about our products and developmental issues. Please call at: +49 (0) 421 / 69 61 62 0 or send your inquiries to Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein!.



Gruppenfoto Molzym 2018 2MP